1. Home
  2. Tocilizumab
  Subject:

Tocilizumab   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Rheumatoid arthritis Methotrexate Rituximab Adalimumab Abatacept Vasculitis Syndrome Stenosis Gene Disease-modifying antirheumatic drug Tocilizumab Osteoarthritis Systemic lupus erythematosus Arthritis Protein Chemotherapy Cyclophosphamide Lymphoma Progression-free survival Etanercept Infliximab Golimumab CTLA-4 Anti-neutrophil cytoplasmic antibody Purpura Obesity Hypertension Phenotype Coronary circulation CT scan Coronary artery disease Coronary catheterization Magnetic resonance imaging DNA Polymerase chain reaction Messenger RNA Acid Logistic regression Juvenile idiopathic arthritis Enzyme inhibitor
RELATED SUBJECTS:
The publications listed also have these subjects
Rheumatoid arthritis  6 times
Methotrexate  6 times
Rituximab  4 times
Adalimumab  4 times
Abatacept  4 times
Vasculitis  3 times
Syndrome  3 times
Stenosis  3 times
Gene  3 times
Disease-modifying antirheumatic drug  3 times
Cyclophosphamide  3 times
Corticosteroid  3 times
Angiography  3 times
Uveitis  2 times
Thrombocytopenia  2 times
Prednisolone  2 times
Necrosis  2 times
Monoclonal antibody  2 times
Medical ultrasound  2 times
Lymph node  2 times
Kidney failure  2 times
Juvenile idiopathic arthritis  2 times
Joint effusion  2 times
Infliximab  2 times
Etanercept  2 times
Critical Role  2 times
Biopsy  2 times
Azathioprine  2 times
Tumor necrosis factor alpha  1 time
Thrombosis  1 time
T-cell receptor  1 time
Systemic scleroderma  1 time
Systemic lupus erythematosus  1 time
Stent  1 time
Shock (circulatory)  1 time
Respiratory disease  1 time
Purpura  1 time
PubMed  1 time
Proportional hazards model  1 time
Prednisone  1 time
Percutaneous coronary intervention  1 time
Peptic ulcer  1 time
Mycophenolic acid  1 time
Mutation  1 time
Multinomial logistic regression  1 time
Messenger RNA  1 time
Magnetic resonance imaging  1 time
Lipid  1 time
Joint stiffness  1 time
Japan  1 time
Ischemia  1 time
International law  1 time
Interleukin 6  1 time
Innate immune system  1 time
Inflammation  1 time
Immunotherapy  1 time
Immunoglobulin G  1 time
Immunoglobulin A  1 time
Idiopathy  1 time
Hypertension  1 time
Grayscale  1 time
Fibrosis  1 time
Fibroblast  1 time
Fever  1 time
Extracellular matrix  1 time
Estrogen receptor  1 time
Erythrocyte sedimentation rate  1 time
Enzyme inhibitor  1 time
Dyslipidemia  1 time
Disease  1 time
Diarrhea  1 time
Diabetic retinopathy  1 time
Coronary circulation  1 time
Coronary catheterization  1 time
Coronary artery disease  1 time
Clinical trial  1 time
Ciclosporin  1 time
Cell surface receptor  1 time
Cartilage  1 time
CD14  1 time
C-reactive protein  1 time
Bioavailability  1 time
B cell  1 time
Axillary lymph nodes  1 time
Arthritis  1 time
Arthralgia  1 time
Antibody  1 time
Anterior interventricular branch of left coronary artery  1 time
Angioplasty  1 time
Angina pectoris  1 time
Anemia  1 time
Acid  1 time

Publications tagged with this subject: 17

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation

2. TAFRO syndrome with a rapid fatal course despite corticosteroid and tocilizumab therapy

3. Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis

4. Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

5. Multicentric Castleman’s disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report

6. IL-6 blockade in the management of non-infectious uveitis

7. An Update on Treatment of Pediatric Chronic Non-infectious Uveitis

8. Current and Future Treatment Options for Takayasu Arteritis and Persistent Therapeutic Challenges

9. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition

10. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis F

11. Recent advances in the treatment of skin involvement in systemic sclerosis

12. Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy

13. The effect of tocilizumab on clinical signs and laboratory findings in rheumatoid arthritis patients resistant to methotrexate

14. Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry

15. Takayasu’s arteritis: a case with relapse after urgent coronary revascularization

16. Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome

17. Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review


Questions?

Drop us a message.